February 9, 2010 - The U.S. Food and Drug Administration says it is starting a program designed to reduce ...
Nuclear Imaging
Nuclear imaging, also called molecular imaging, includes positron emission computed tomography (PET) and single photon emission computed tomography (SPECT) imaging. This section includes radiopharmaceuticals and tracers, PET-CT, SPECT-CT, and PET-MRI.
February 2, 2010 - Two protocols for reduced-dose cardiac imaging, without compromising image quality, may help ...
February 02, 2010
January 26, 2010 – The U.S. Department of Energy’s National Nuclear Security Administration (NNSA) selected GE ...
January 26, 2010January 25, 2010 - Heart failure is a serious medical condition, in which the heart muscle progressively loses its ...
January 25, 2010
December 29, 2009 - Imaging is at the heart of diagnostic procedures and is the focus of the "ESC Textbook of ...
December 29, 2009
December 28, 2009 - The Medical College of Wisconsin will license a novel molecular imaging technology designed ...
December 28, 2009
December 18, 2009 - The U.S. radiopharmacy network currently owned by Covidien is being sold to Triad Isotopes in ...
December 18, 2009December 9, 2009 - An expert panel reviewing Canadian medical isotope productions selected electron beam ...
December 09, 2009
December 9, 2009 – Research published in the December issue of The Journal of Nuclear Medicine (JNM) suggests ...
December 09, 2009November 23, 2009 — SNM will hold its Conjoint Mid-Winter Meetings on Jan. 27-Feb. 2, 2010, at the Albuquerque ...
December 01, 2009
Feature | Dave Fornell
With new CPT reimbursement codes for cardiac computed tomography (CT) starting in January 2010, there will likely ...
November 18, 2009
November 18, 2009 – The Centers for Medicaid and Medicare Services (CMS) recently announced it will increase the ...
November 18, 2009
Feature | Cristen C. Bolan
Our profession faces one of the most significant crises in its history,” said Michael Graham, M.D., president of ...
November 18, 2009
Feature | Stephanie LaBelle, senior analyst, Millennium Research Group
In recent years, the U.S. cardiac device market has focused on dynamics in the drug-eluting stent (DES) segment – ...
November 18, 2009
November 13, 2009 – A new imaging agent for measuring and monitoring cathepsin B activity associated with disease ...
November 13, 2009© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now